While a number of new therapeutic agents have been approved to treat the signs of rosacea, much needed research is underway to better understand its pathogenesis.

While anyone can present with rosacea, this condition is often underdiagnosed among patients with darker phototypes. Dr Susan Taylor shares her clinical pearls for identifying rosacea in patients with skin of color.

The FDA has approved a new topical foam medication for the treatment of inflammatory lesions caused by rosacea in adults.

The number of therapeutic options for rosacea management has expanded, but these treatments can only help patients who have been diagnosed. Rosacea Awareness Month seeks to help identify patients who may otherwise ignore their warning signs.